Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.54
+0.03 (0.40%)
At close: Apr 28, 2026, 4:00 PM EDT
7.60
+0.06 (0.80%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Puma Biotechnology Employees
Puma Biotechnology had 179 employees as of December 31, 2025. The number of employees increased by 7 or 4.07% compared to the previous year.
Employees
179
Change (1Y)
7
Growth (1Y)
4.07%
Revenue / Employee
$1,275,816
Profits / Employee
$173,804
Market Cap
383.61M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Rocket Pharmaceuticals | 202 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Century Therapeutics | 78 |
| Lineage Cell Therapeutics | 77 |
| Immuneering | 53 |
| X4 Pharmaceuticals | 45 |
PBYI News
- 5 days ago - Puma Biotechnology to Host Conference Call to Discuss First Quarter 2026 Financial Results - Business Wire
- 26 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Puma Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Puma Biotechnology Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Puma Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 2 months ago - Puma Biotechnology to Present at TD Cowen's 46th Annual Health Care Conference - Business Wire
- 2 months ago - Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 4 months ago - Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI) - Business Wire